Difference between revisions of "OpenSourceMalaria:GSK Amino-thienopyrimidine Series"

From OpenWetWare
Jump to: navigation, search
(GSK Thienopyrimidine Series)
Line 6: Line 6:
[[Image:thienopyrimidine.PNG|thumb|center|180px|GSK Thienopyrimidine Series: TCMDC 135294]]
[[Image:thienopyrimidine.PNG|thumb|center|180px|GSK Thienopyrimidine Series: TCMDC 135294]]
The above compound is one part of a duo...(detail goes here).
[https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL581088 | chEMBL]
[https://www.chemspider.com/Chemical-Structure.24575349.html?rid=a5689148-4b7f-4b14-b9e6-7d03c39148df | ChemSpider]
The proposed synthesis for this compound is below:
The proposed synthesis for this compound is below:

Revision as of 04:50, 7 February 2012

Malaria Scheme.png

Malaria Home        OSM So Far        Compound Series        Links        Open Source Research Home        Tech Ops        FAQ       

GSK Thienopyrimidine Series

The series lead has the following generic structure:

GSK Thienopyrimidine Series: TCMDC 135294

| chEMBL | ChemSpider

The proposed synthesis for this compound is below:

Proposed synthesis for the above compound


| Baykal, A. T.; Kakalis, L.; Jordan, F., Electronic and nuclear magnetic resonance spectroscopic features of the 1 ',4 '-iminopyrimidine tautomeric form of thiamin diphosphate, a novel intermediate on enzymes requiring this coenzyme. Biochemistry 2006, 45 (24), 7522-7528.

Castenado, G.; Dotson, J.; Goldsmith, R.; Gunzo, J.; Heffron, T.; Mathieu, S.; Oliveo, A.; Staben, S.; Sutherlin, D.P.; Tsui, V.; Wang, S.; Zhu, B.; Bayliss, T.; Chuckowree, I.; Folkes, A.; Wan, N.C. (Genentech, Inc., USA; Piramed Limited). Thienopyrimidine and furopyrimidine derivatives as phosphoinositide 3-kinase inhibitor and their preparation, pharmaceutical compositions and use in the treatment of cancer. World Intellectual Property Organisation 2008073785 A2, 2008; SciFinder Scholar AN 2008:735944 (accessed 2/2/2012).

| Diel, B. N.; Han, M. C.; Kole, P. L.; Boaz, D. B., Synthesis of (C-13(6)-Ring-(U))-(+/-)-benzo(a)pyrene metabolites from (C-13(6)-Ring-(U))benzene. Journal of Labelled Compounds & Radiopharmaceuticals 2007, 50 (5-6), 551-553.

Son, J.B.; Jung, S. H.; Choi, W.I.; Jung, Y.H.; Choi, J.Y.; Song, J.Y.; Lee, K.H.; Lee, J.C.; Kim, E.Y.; Ahn, Y.G.; Kim, M.S.; Choi, HG.; Sim, T.B.; Ham, Y.J.; Park, D.; Kim, H.; Kim, D. (Hanmi Holdings Co., Ltd., S. Korea; Korea Institute of Science and Technology; Catholic University Industry Academic Cooperation Foundation). Preparation of thienopyrimidine derivatives for use as protein kinase inhibitors. World Intellectual Property Organisation 2011093684 A2, 2011; SciFinder Scholar AN 2011:971406 (accessed 3/2/2012).